Breaking News
Israeli chief of staff officially approves plan to occupy Gaza City
Report From "Blueprint for Peace"
The Remote Access Car . . .
Are They Lying to Us About Inflation?
Top Tech News
Chinese Scientists Produce 'Impossible' Steel to Line Nuclear Fusion Reactors in Major Break
1,000 miles: EV range world record demolished ... by a pickup truck
Fermented Stevia Extract Kills Pancreatic Cancer Cells In Lab Tests
3D printing set to slash nuclear plant build times & costs
You can design the wheels for NASA's next moon vehicle with the 'Rock and Roll Challenge
'Robot skin' beats human reflexes, transforms grip with fabric-powered touch
World's first nuclear fusion plant being built in US to power Microsoft data centers
The mitochondria are more than just the "powerhouse of the cell" – they initiate immune...
Historic Aviation Engine Advance to Unlock Hypersonic Mach 10 Planes
OpenAI CEO Sam Altman Pitches Eyeball-Scanning World ID to Bankers
Nanotech platform Carries mRNA Directly to Target Cells
The groundbreaking method may prove useful in treating myriad malignancies, inflammatory diseases and rare genetic disorders.
Lipid nanoparticles (LNP) were used to deliver modified messenger RNA to treat inflammatory bowel diseases and other diseases.
Prof. Dan Peer, Molecular Cell Biology at TAU's Faculty of Life Sciences, led the research for the new study.
Over the past few years, lipid carriers encapsulating messenger RNAs (mRNAs) have been shown to be extremely useful in altering the protein expressions for a host of diseases. But directing this information to specific cells has remained a major challenge.
"In our new research, we utilized mRNA-loaded carriers — nanovehicles carrying a set of genetic instructions via a biological platform called ASSET — to target the genetic instructions of an anti-inflammatory protein in immune cells," says Prof. Peer.